Trenary C Russell Iii - Net Worth and Insider Trading
Trenary C Russell Iii Net Worth
The estimated net worth of Trenary C Russell Iii is at least $5,629 dollars as of 2024-12-02. Trenary C Russell Iii is the CEO and President of Outlook Therapeutics Inc and owns about 2,746 shares of Outlook Therapeutics Inc (OTLK) stock worth over $5,629. Details can be seen in Trenary C Russell Iii's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Trenary C Russell Iii has not made any transactions after 2022-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Trenary C Russell Iii
Trenary C Russell Iii Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Trenary C Russell Iii owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Trenary C Russell Iii’s form 4 insider trades.
Insider Ownership Summary of Trenary C Russell Iii
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2022-06-21 | director & CEO and President |
Trenary C Russell Iii Latest Holdings Summary
Trenary C Russell Iii currently owns a total of 1 stock. Trenary C Russell Iii owns 2,746 shares of Outlook Therapeutics Inc (OTLK) as of June 21, 2022, with a value of $5,629.
Latest Holdings of Trenary C Russell Iii
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2022-06-21 | 2,746 | 2.05 | 5,629 |
Holding Weightings of Trenary C Russell Iii
Trenary C Russell Iii Form 4 Trading Tracker
According to the SEC Form 4 filings, Trenary C Russell Iii has made a total of 3 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 996 shares on June 21, 2022, which cost Trenary C Russell Iii around $21,121.
Insider Trading History of Trenary C Russell Iii
- 1
Trenary C Russell Iii Trading Performance
GuruFocus tracks the stock performance after each of Trenary C Russell Iii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Trenary C Russell Iii is 21.57%. GuruFocus also compares Trenary C Russell Iii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Trenary C Russell Iii within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Trenary C Russell Iii's insider trading performs compared to the benchmark.
Performance of Trenary C Russell Iii
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.5 | | | | | |
| Relative Return to S&P 500(%) | -1.71 | | | | | |
Trenary C Russell Iii Ownership Network
Trenary C Russell Iii Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Trenary C Russell Iii is the director & CEO and President of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include CFO and Secretary Lawrence A Kenyon , Chief Commercial Officer Jeff Evanson , and Chief Operating Officer Terry Dagnon .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Trenary C Russell Iii made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 62,484 shares made by Jeff Evanson , a net purchase of 5,000 shares made by Lawrence A Kenyon , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Trenary C Russell Iii Mailing Address
Above is the net worth, insider trading, and ownership report for Trenary C Russell Iii. You might contact Trenary C Russell Iii via mailing address: 1700 E St Andrew Place, Santa Ana Ca 92705.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
